가금류 세균병 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)

The future of the global poultry bacterial disease vaccine market looks promising with opportunities in the NDV, Marek's disease, IBD, infectious bronchitis, and influenza markets. The global poultry bacterial disease vaccine market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising demand for poultry products, the growing awareness of animal health, and regulatory requirements.

• Lucintel forecasts that, within the type category, killed will remain the largest segment over the forecast period due to its widespread acceptance for poultry disease prevention.
• Within the application category, infectious bronchitis will remain the largest segment due to its high prevalence and impact on poultry health.
• In terms of region, APAC is expected to witness the highest growth over the forecast period due to high poultry production.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Poultry Bacterial Disease Vaccine Market

With rising attention on poultry health and its dependency on the use of antibiotics, the worldwide poultry bacterial disease vaccine market is changing with various emerging trends. There are innovations going on in terms of vaccine technology and growing concern for food safety as well. Trends that are in focus for further modification of the poultry bacterial disease market are as follows:

• Prevention of AMR: The issue of antimicrobial resistance places the poultry industry at a crossroads, and the sector has been changing to provide a more strategic alternative: vaccines. Vaccines protect birds from bacterial infections without antibiotics, reducing AMR. Manufacturers have trended toward the production of vaccines that target common poultry diseases such as Salmonella and E. coli. Such a vaccine helps keep bacterial infection at bay but does not encourage resistance. This trend is significant as governments and consumers call for clean and safe meat products.
• Recombinant and DNA-Based Vaccines: The use of recombinant and DNA-based vaccines is on the rise in the poultry industry. Such vaccines are specific and work efficiently with respect to the bacterial type for which they have been developed. They generally have minimal side effects. Their safety to poultry and consumers is enhanced because they are able to elicit a good immune response, but in the absence of live pathogens. Furthermore, DNA vaccines are easier to produce and scale, hence are relatively cheaper for large-scale poultry farming operations, especially in developing markets.
• Customizable and Multi-Strain Vaccines: The development of customizable and multi-strain vaccines that would be an effective tool for broad protection against several bacterial pathogens is increasing in prevalence. Multi-strain vaccines are more sought after today since they provide poultry immunity to a variety of bacterial diseases by taking one vaccine dose. This cuts the need for vaccination and streamlines the vaccination of poultry farms.
• Innovation in Vaccine Delivery Systems: Vaccine delivery systems innovation is becoming the most significant trend in the poultry vaccine market. Replacing the traditional injection methods, more efficient and less stressful methods, such as oral vaccines and water-based delivery systems, are being considered. These have a reduced time of handling, stress to the birds, and overall welfare improvement, and better vaccine uptake. Vaccine delivery innovations also ensure there is better coverage and more accurate dosing, leading to the overall success of campaigns for vaccination, especially in poultry farming on large scales.
• Increased Government Support and Regulation: Governments around the world are playing a more active role in regulating poultry health and vaccine use. As concerns over food safety and disease prevention grow, most countries will have stronger regulations for vaccination in their poultry, especially regarding bacterial diseases. This regulatory push is forcing the demand for vaccines as part of national disease control programs. Moreover, governments are increasingly supporting research and development in vaccine technology, which is making manufacturers invest in new vaccine formulations that meet strict safety and efficacy standards.

The emerging trends in the poultry bacterial disease vaccine market, including the focus on antimicrobial resistance prevention, recombinant vaccines, multi-strain formulations, vaccine delivery innovations, and increased government support, are significantly reshaping the industry. These trends are improving poultry health, enhancing disease control efforts, and contributing to safer, antibiotic-free poultry production.

Recent Developments in the Poultry Bacterial Disease Vaccine Market

The poultry bacterial disease vaccine market is undergoing significant development as manufacturers and researchers work to address the challenges of bacterial infections in poultry. Recent developments are focused on improving vaccine efficacy, expanding accessibility, and reducing reliance on antibiotics. The following developments highlight how the industry is evolving to meet the needs of poultry health.

• Advances in Recombinant Vaccine Technology: Recombinant vaccines are changing the dynamics of poultry bacterial disease vaccines. Genetic engineering in producing recombinant vaccines develops a safer, more effective product for use by specific strains without having to go through the traditional path of utilizing live pathogens. Their specificity level and reduced side effects contribute to the gain of these recombinant vaccines, making them progressively popular for immunity protection of birds from Salmonella and E. coli, and Mycoplasma infections, thus improving poultry health as well as reducing the need for antibiotics.
• Vaccine Development in New Markets: There is an increased demand for affordable and accessible poultry vaccines in new markets. Manufacturers are fulfilling this demand by making these vaccines accessible to larger markets. New vaccine formulations are emerging that are of relatively low cost and ideal for large poultry farms. This expansion is vital for controlling bacterial diseases in regions with high poultry production but limited access to veterinary care. It also helps in global efforts to ensure food safety and poultry health.
• Improved Vaccine Delivery Systems: New innovations in vaccine delivery systems are helping to improve the efficiency of vaccination, thus reducing the stress on poultry. Oral vaccines and water-based vaccines are methods that are currently being developed for easy administration, thereby reducing handling time. The systems are advantageous for large poultry farms, as they decrease labor costs and ensure more uniform distribution of the vaccine. Vaccination coverage has increased due to the adoption of improved delivery systems, resulting in better disease prevention and overall poultry health.
• Collaborations Between Government and Private Sector: Collaboration between governments and other private sector units is becoming important in the area of poultry bacterial disease vaccine formulation and distribution. Public-Private Partnerships are facilitating acceleration in vaccine production and the institutionalization of universal vaccination programs in the country. Governments are supporting R&D, providing regulatory clearances, and supplies to farmers at the grassroots level, whereas the private sector is bringing technologically advanced areas and manufacturing facilities. This integration is helping with vaccine availability and implementation across many regions.
• Shift toward Raising Antibiotic-Free Poultry: Consumer awareness and demand are forcing the international community to concentrate on producing safer and healthier antibiotic-free poultry products. This aspect is encouraging the poultry industry to focus on vaccine-based disease control instead of antibiotic use. There has been a focus from manufacturers on making vaccines that not only offer broad-spectrum bacterial protection but do not involve antibiotic drugs. This development is crucial in addressing the concerns associated with antibiotic resistance and ensuring the sustainability of poultry farming in the long term.

Recent developments in the poultry bacterial disease vaccine market, such as advancements in recombinant technology, expanded vaccine options, improved delivery systems, public-private collaborations, and a focus on antibiotic-free poultry production, are reshaping the industry. These innovations are improving poultry health, reducing reliance on antibiotics, and ensuring safer, more sustainable poultry production worldwide.

Strategic Growth Opportunities in the Poultry Bacterial Disease Vaccine Market

The global poultry bacterial disease vaccine market is expected to grow with increased poultry production and heightened awareness about disease prevention. Strategic growth opportunities exist across a number of key applications, such as joint efforts in improving poultry health, increasing vaccine access, and reducing the impact of bacterial diseases. The following sections identify five key growth opportunities in the market.

• Development of Tailored Vaccines for Emerging Markets: One major growth area is in the case of emerging markets, such as poultry bacterial disease vaccines. Regions with difficulties and limited veterinary services in regard to disease control constitute a critical gap that can be exploited through designing cost-effective, region-specific vaccines for the specific needs of poultry farms. Manufacturers would improve poultry health by making the vaccine more accessible at a low price in production-intensive, but resource-poor, regions.
• Expansion of Vaccine Delivery Innovations: Innovations in vaccine delivery systems, such as oral vaccines and water-based delivery methods, represent a major growth opportunity. These systems offer a less invasive and more efficient way to vaccinate large flocks, reducing stress on poultry and improving vaccine uptake. Expanding the use of these delivery methods, particularly in large-scale poultry operations, will improve vaccination coverage and lead to better disease prevention and poultry health management.
• Inter-government, inter-institutional, and public-private collaborations in research and development will provide significant growth opportunities in the poultry vaccine market. Inter-government, inter-institutional, and public-private collaboration in research and development will facilitate accelerating the development of new vaccine formulations, development of more effective vaccines, and expansion of the coverage of vaccination programs. With joint resources and expertise, stakeholders can leverage their differences and challenge barriers toward developing safe and efficacious vaccines for poultry worldwide.
• Focus on Sustainable and Antibiotic-Free Poultry Production: With the rising demand for antibiotic-free poultry, manufacturers will find a good opportunity to develop vaccines that prevent bacterial diseases without antibiotics. Consumers' growing desire for safer and more sustainable meat products will lead to further demand for vaccines as an alternative to antibiotics. Therefore, this trend toward antibiotic-free production methods will drive growth in the poultry bacterial disease vaccine market.
• Increase Support towards Poultry Health Programs: Growth opportunities for vaccine manufacturers to improve poultry health arise from initiatives undertaken by governments. Stricter regulations and guidelines for countries in terms of poultry disease prevention are creating immense pressure to put effective vaccination programs in place, thus creating further opportunities for manufacturers by being aligned to national health initiatives and providing vaccines that are of regulatory requirement quality. By contributing to these public health programs, vaccine manufacturers can expand market presence and achieve better disease control worldwide.

Strategic growth opportunities in the poultry bacterial disease vaccine market are centered around developing tailored vaccines for emerging markets, expanding vaccine delivery innovations, fostering research collaborations, focusing on antibiotic-free production, and supporting government health initiatives. These opportunities will drive market expansion while improving poultry health and ensuring safer, more sustainable poultry production.

Poultry Bacterial Disease Vaccine Market Driver and Challenges

The global poultry bacterial disease vaccine market is driven by several technological, economic, and regulatory drivers and challenges. These factors determine the development, production, and distribution of vaccines intended to improve poultry health and reduce bacterial infections. Understanding these drivers and challenges will help in the navigation of the market dynamics.

The factors responsible for driving the poultry bacterial disease vaccine market include:

1. Technological Advancements in Vaccine Development: Advances in vaccine development technology, for instance, recombinant DNA and developed vaccine delivery systems, are key factors of this market. Such advancements provide more effective vaccines and the immunity that results from them, especially against certain strains of bacteria, help poultry be better managed for health and productivity.

2. Increased demand for antibiotic-free poultry: Increasing consumer preference for antibiotic-free poultry is driving demand for vaccines as an alternative to antibiotics in disease prevention. Vaccines help protect poultry from bacterial infections without contributing to antimicrobial resistance, aligning with consumer expectations for safer, healthier meat products. This shift is encouraging the adoption of vaccines in the poultry industry.

3. Government Regulations and Health Initiatives: Demand for poultry bacterial disease vaccines is mainly driven by more stringent government regulations in the area of poultry health and disease prevention. Most governments have adopted vaccination programs and higher standards for poultry disease control, thereby increasing the usage of vaccines in poultry farms worldwide.

4. Increase in Poultry Production: In such a scenario of increasing global poultry production, disease prevention measures must become more effective. The growing demand for poultry products is pushing for the use of vaccines as a means to control bacterial diseases and reduce mortality with an improvement in overall flock health.

5. Food Safety and Public Health Awareness are on the Rise: Heightened awareness of food safety and public health concerns is increasing the demand for vaccines in poultry farming. Consumers are more aware of the potential risks associated with bacterial infections in poultry, which has led to a greater emphasis on preventive measures, including vaccination.

Challenges in the poultry bacterial disease vaccine market are:

1. High Cost of Vaccine Development: The main barrier in the poultry bacterial disease vaccine market is the high cost of developing a new vaccine. Research and development require a lot of time, resources, and expertise. This usually proves to be a challenge for smaller companies to venture into the market and provide vaccines for farmers in developing countries.

2. Issues Surrounding Vaccine Distribution and Storage: Efficient distribution and storage of vaccines, especially in regions with limited infrastructure, remain a challenge. Vaccines often require specific storage conditions, such as refrigeration, which can complicate their distribution in rural areas or developing countries. Overcoming these logistical hurdles is essential for ensuring broad vaccine access.

3. Limited Vaccine Efficacy for Some Strains: Another challenge is the limited efficacy of vaccines for certain bacterial strains. While vaccines for some diseases, such as Salmonella, are widely available, there are still gaps in vaccine development for less common bacterial pathogens. Further research is needed to develop vaccines that offer broad protection against a wider range of bacteria.

Drivers for the global poultry bacterial disease vaccine include recent advances in technology, increasing consumer demand for antibiotic-free poultry, government regulations, and growth in poultry production. There is also awareness of food safety. The market growth would be a hurdle against some of the challenges including the high cost of vaccine development, issues of distribution and storage, as well as the limited efficacy for certain strains. These challenges would have to be addressed in order to extend and increase the poultry vaccines' global reach and impact.

List of Poultry Bacterial Disease Vaccine Companies

• Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, poultry bacterial disease vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the poultry bacterial disease vaccine companies profiled in this report include:
• Merck
• Boehringer Ingelheim
• Ceva
• Zoetis
• Vaxxinova(R)
• Elanco
• Qyh Biotech Co.
• Hester Biosciences
• Pulike
• Phibro Animal Health Corporation

Poultry Bacterial Disease Vaccine Market by Segment

The study includes a forecast for the global poultry bacterial disease vaccine market by type, application, and region.

Poultry Bacterial Disease Vaccine Market by Type [Value from 2019 to 2031]:

• Live
• Attenuated
• Killed

Poultry Bacterial Disease Vaccine Market by Application [Value from 2019 to 2031]:

• NDV
• Marek's Disease
• IBD
• Infectious Bronchitis
• Influenza
• Others

Poultry Bacterial Disease Vaccine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Poultry Bacterial Disease Vaccine Market

The global poultry bacterial disease vaccine market has grown by leaps and bounds with the increased demand for poultry health management and the rising awareness of the importance of disease prevention. Bacterial diseases such as Salmonella, Escherichia coli, and Pasteurella are significant threats to poultry production and have led to increased demand for effective vaccines. Technological advancements in the formulation of vaccines, along with effective regulatory frameworks, have also paved the way for market growth. The United States, China, Germany, India, and Japan are key leaders in this market, all developing innovative solutions to curb bacterial diseases among poultry.

• United States: In the United States, the market for poultry bacterial disease vaccines has grown with great inventions in vaccine technology. The USDA has been very crucial in promoting the licensing and utilization of vaccines for protection against a wide range of bacterial infections of poultry. Manufacturers of vaccines in the U.S. are now focusing on the advanced formulations of live attenuated vaccines and subunit vaccines for particular pathogens. This has also steered the emphasis towards vaccine development as part of the broader strategy aimed at reducing antibiotic use in poultry. These innovations help to improve the health of poultry and ensure safety in poultry products.
• China: China is the world's largest producer and consumer of poultry. The poultry bacterial disease vaccine market is gaining considerable momentum. This is also because of the rapid growth of the country in the poultry production sectors, where more effective strategies in disease prevention have been increased. Chinese manufacturers increasingly adopt modern vaccine technologies, such as recombinant DNA vaccines, in combating bacterial diseases such as Salmonella and E. coli. Furthermore, the government in China has placed stricter regulations regarding poultry health, hence pushing the demand for effective vaccines. Local research and development activities also help generate affordable vaccines, which are essential for small- and medium-sized poultry farms.
• Germany: Germany is one of the leading poultry bacterial disease vaccine markets in Europe, known for its strict regulation and advanced technologies of vaccines. In Germany, local manufacturers are designing multi-strain vaccines that can cover a wide variety of bacterial pathogens, including Pasteurella and E. coli. The country's strong research and development ecosystem ensures that vaccines will continue to be innovated against both national and international standards. A growing consumer preference in the German market for sustainably produced poultry is forcing market forces toward the adoption of more sustainable applications through vaccines, which minimize antibiotic use and improve poultry health in an environmentally friendlier manner.
• India: The Indian poultry bacterial disease vaccine market is developing because of India's thriving poultry industry. The country is facing significant challenges related to poultry diseases. In rural and semi-urban areas, veterinary care is not easily available. In turn, the demand for affordable and effective vaccines is increasing rapidly. Indian manufacturers are targeting low-cost vaccines that are also multi-valent against bacterial diseases, such as Salmonella and Avian Cholera. The government also supports vaccination programs in poultry for healthy production, which has a direct bearing on food safety and the economics of the poultry industry.
• Japan: Japan is known for its development of advanced and highly specific poultry health vaccines. The market is highly competitive, mainly due to the strict regulatory requirements and emphasis on biosecurity that Japan sets. Companies in Japan are using advanced biotechnologies for developing specific-strain vaccines against bacteria, such as Mycoplasma gallisepticum and E. coli. Consumers' increasing demand for safe, antibiotic-free poultry products is another market driver. With the emphasis of the country on technological advancements and high-quality production standards, Japan's poultry vaccine market keeps innovating in order to guarantee the healthiness of its poultry industry.

Features of the Global Poultry Bacterial Disease Vaccine Market

• Market Size Estimates: Poultry bacterial disease vaccine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Poultry bacterial disease vaccine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Poultry bacterial disease vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the poultry bacterial disease vaccine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the poultry bacterial disease vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the poultry bacterial disease vaccine market by type (live, attenuated, and killed), application (NDV, Marek's disease, IBD, infectious bronchitis, influenza, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Poultry Bacterial Disease Vaccine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Live: Trends and Forecast (2019-2031)
• 4.4 Attenuated: Trends and Forecast (2019-2031)
• 4.5 Killed: Trends and Forecast (2019-2031)

5. Global Poultry Bacterial Disease Vaccine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 NDV: Trends and Forecast (2019-2031)
• 5.4 Marek's Disease: Trends and Forecast (2019-2031)
• 5.5 IBD: Trends and Forecast (2019-2031)
• 5.6 Infectious Bronchitis: Trends and Forecast (2019-2031)
• 5.7 Influenza: Trends and Forecast (2019-2031)
• 5.8 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Poultry Bacterial Disease Vaccine Market by Region

7. North American Poultry Bacterial Disease Vaccine Market

• 7.1 Overview
• 7.2 North American Poultry Bacterial Disease Vaccine Market by Type
• 7.3 North American Poultry Bacterial Disease Vaccine Market by Application
• 7.4 United States Poultry Bacterial Disease Vaccine Market
• 7.5 Mexican Poultry Bacterial Disease Vaccine Market
• 7.6 Canadian Poultry Bacterial Disease Vaccine Market

8. European Poultry Bacterial Disease Vaccine Market

• 8.1 Overview
• 8.2 European Poultry Bacterial Disease Vaccine Market by Type
• 8.3 European Poultry Bacterial Disease Vaccine Market by Application
• 8.4 German Poultry Bacterial Disease Vaccine Market
• 8.5 French Poultry Bacterial Disease Vaccine Market
• 8.6 Spanish Poultry Bacterial Disease Vaccine Market
• 8.7 Italian Poultry Bacterial Disease Vaccine Market
• 8.8 United Kingdom Poultry Bacterial Disease Vaccine Market

9. APAC Poultry Bacterial Disease Vaccine Market

• 9.1 Overview
• 9.2 APAC Poultry Bacterial Disease Vaccine Market by Type
• 9.3 APAC Poultry Bacterial Disease Vaccine Market by Application
• 9.4 Japanese Poultry Bacterial Disease Vaccine Market
• 9.5 Indian Poultry Bacterial Disease Vaccine Market
• 9.6 Chinese Poultry Bacterial Disease Vaccine Market
• 9.7 South Korean Poultry Bacterial Disease Vaccine Market
• 9.8 Indonesian Poultry Bacterial Disease Vaccine Market

10. ROW Poultry Bacterial Disease Vaccine Market

• 10.1 Overview
• 10.2 ROW Poultry Bacterial Disease Vaccine Market by Type
• 10.3 ROW Poultry Bacterial Disease Vaccine Market by Application
• 10.4 Middle Eastern Poultry Bacterial Disease Vaccine Market
• 10.5 South American Poultry Bacterial Disease Vaccine Market
• 10.6 African Poultry Bacterial Disease Vaccine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Poultry Bacterial Disease Vaccine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Merck
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Boehringer Ingelheim
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Ceva
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Zoetis
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Vaxxinova(R)
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Elanco
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Qyh Biotech Co.
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Hester Biosciences
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Pulike
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Phibro Animal Health Corporation
  • Company Overview
  • Poultry Bacterial Disease Vaccine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us